1. |
王清香, 贾淑梅. 奥卡西平结合心理疗法治疗青少年癫痫120例 疗效观察. 安徽医药, 2019, 23(4): 812.
|
2. |
陈艳平, 鲁虹, 史群志, 等. 高效液相色谱法测定人血 浆中奥卡西平及其活性代谢产物的浓度. 中南药学, 2016, 14(6): 616-619.
|
3. |
陈新谦, 金有豫, 汤光. 新编药物学. 第16 版. 北京: 人民卫生出版社, 2007: 221.
|
4. |
Kaufman DW, Shapiro S. Epidemiological assessment of druginduced disease. Lancet, 2000, 356(9238): 1339-1343.
|
5. |
Arif H, Buchsbaum R, Weintraub D, <italic>et al</italic>. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology, 2007, 68(20): 1701-1709.
|
6. |
Pratoomsri W, Yatham LN, Bond DJ, <italic>et al</italic>. Oxcar- bazepine in the treatment of bipolar disorder: a review. Can J Psychiatry, 2006, 51(8): 540-545.
|
7. |
江帆. 美国(版)奥卡西平说明书中增加新的警告. 中国药师, 2006, 9(6): 571.
|
8. |
Chen M, Yang B, Wang C, <italic>et al</italic>. Oxcarbazepine-induced Stevens-Johnson syndrome in a patient with HLA-B*1502 genotype. Australas J Dermatol, 2016, 57(4): e137-e138.
|
9. |
Hung SI, Chung WH, Chen YT. HLA-B genotyping to detect carbamazepine-induced Stevens-Johnson syndrome:Implications for personalizing medicine. Personal Med, 2005, 2(3): 225-237.
|
10. |
Laska AJ, Han MJ, Lospinoso JA, <italic>et al</italic>. Brown PJ, Beachkofsky TM. CYP2C19*2 status in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmgenomics Pers Med, 2017, 10: 183-186.
|
11. |
Franco V, Perucca E. The pharmacogenomics of epilepsy. Expert Rev Neurother, 2015, 15(10): 1161-1170.
|
12. |
韩翔宇, 王菊莉, 曹洪涛, 等. 奥卡西平诱发轻微皮肤不良反应 与 HLA 等位基因相关性的研究. 黑龙江医药科学, 2016, 39(1): 39-40.
|
13. |
Tangamornsuksan W, Scholfield N, Lohitnavy M. Association between HLA genotypes and oxcarbazepine-induced cutaneous adverse drug reactions: a systematic reviewand meta-analysis. J Pharm Pharm Sci, 2018, 21(1): 1-18.
|
14. |
Chung WH, Hung SI. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis. J Der- matol Sci, 2012, 66(3): 190-196.
|
15. |
Zeng T, Long YS, Min FL, <italic>et al</italic>. Association of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in han Chinese subjects: a meta-analysis. Int J Dermatol, 2015, 54(4): 488-493.
|
16. |
Choi H, Mohit B. Cost-effectiveness of screening for HLA-B*1502 prior to initiation of carbamazepine in epilepsy patients of asian ancestry in the united states. Epilepsia, 2019, 60(7): 1472-1481.
|